Fierce Biotech reminds us of 20 major alliances that were established between pharma companies and academic institutions in 2012. This reflected a shift towards down-sizing R&D groups in pharma companies -- particularly those with steep patent cliffs over the past 3 years -- and more investment with outsource partners. In this case, those partners were academic institutions.
Check out the list and learn where Big Pharma is placing its bets and seeding projects that could yield big-time products in the future --- at least that is the strong desire.
Posted by Bruce Lehr Oct 3rd 2012.